Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012.

Authors :: Chau-Ting Yeh
Kung-Hao Liang
Ming-Ling Chang
Chao-Wei Hsu
Yi-Cheng Chen
Chih-Lang Lin
Wey-Ran Lin
Ming-Wei Lai
Yeh, Chau-Ting
Liang, Kung-Hao
Chang, Ming-Ling
Hsu, Chao-Wei
Chen, Yi-Cheng
Lin, Chih-Lang
Lin, Wey-Ran
Lai, Ming-Wei
Source :: Emerging Infectious Diseases. May2017, Vol. 23 Issue 5, p820-822. 3p.
Publication Year :: 2017
Abstract: We examined the characteristic changes of hepatitis B virus (HBV) in antiviral drug treatment-naive patients referred for pretreatment evaluation in Taiwan during 2008-2012. Over time, we observed substantial decreases in the prevalence of HBV e antigen (HBeAg) and increasing prevalence of the precore G1899A mutation and HBV-DNA levels in HBeAg-positive patients. [ABSTRACT FROM AUTHOR]

Subjects :: *HEPATITIS B treatment
*ANTIVIRAL agents
*PHENOTYPES
*GENOTYPES
*VIRAL mutation
*HEPATITIS associated antigen
*PUBLIC health

Full Text Access

Tools